October 29, 2014
The Ministry of Health, Labor and Welfare (MHLW) notified healthcare professionals in its pharmaceutical safety information bulletin on October 28 that the package insert of Pfizer Japan’s pain treatment Lyrica (pregabalin) was revised to add two more possible adverse reactions...read more